What is the Impact Factor of Reumatologia?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Reumatologia is 2.50, ranking in quartile Q3 of Web of Science (ESCI).

Is Reumatologia indexed in Web of Science or Scopus?

Yes, Reumatologia is indexed in Web of Science (ESCI, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.620 (Q3) and an H-index of 33.

Who publishes Reumatologia and what is the Article Processing Charge (APC)?

Reumatologia is published by Termedia Publishing House Ltd.. It operates under a Diamond Open Access model, exempting authors completely from Article Processing Charges ($0 USD APC).

WoS ESCI Q3Scopus Q3SCImago #9,496Diamond OAHybrid

Reumatologia

Identifier (ISSN):0034-6233(Print)/2084-9834(Online)

•

Publisher:Termedia Publishing House Ltd.

Clarivate JCR Index Advisory: Active (ESCI)

Official Website Submission Portal Compare

Clarivate IF (2026)

2.5↑ +0.8

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Reumatologia

WoS Q3

Annual Impact Factor Metric

Current (2026):2.5

Scopus SJR & RankScopus Q3

0.62

#9,496

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

33 papers with at least that number of citations each

WoS: ESCIQ3

Self-Citation Rate7.1%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

73articles/year

99.37% Gold OA•0% Original Research

Aims & Scope

Reumatologia (ISSN: 0034-6233) is a peer-reviewed international scholarly journal in the field of Medicine, published by Termedia Publishing House Ltd. in Poland. The periodical holds a Journal Impact Factor (JIF) of 2.50, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.620 (Q3), an H-index of 33.

Topics Covered (Recognized by AI)

MedicineBiology79%Internal medicine76.2%Immunology61.3%Pathology45.9%Dermatology33.8%Rheumatoid arthritis31.9%Genetics29.7%Surgery28%Disease25.7%Psychology22.3%

Primary Research Areas

Medicine Rheumatology

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

RHEUMATOLOGY

Rank31/58

IndexESCI

JCIESCI2026

RHEUMATOLOGY

Rank39/58

IndexESCI

Category	Index	Rank	Quartile
RHEUMATOLOGY	JCRESCI	31/58	Q3
RHEUMATOLOGY	JCIESCI	39/58	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.5

Articles / Year73

Total Citations2

2025

IF1.7

Articles / Year78

Total Citations82

2024

IF1.4

Articles / Year167

Total Citations232

2023

IF0

Articles / Year56

Total Citations446

2022

IF—

Articles / Year66

Total Citations430

Year	Impact Factor	Articles / Year	Total Citations
2026	2.5	73	2
2025	1.7	78	82
2024	1.4	167	232
2023	0	56	446
2022	—	66	430
2021	—	69	729
2020	—	77	952
2019	—	68	898
2018	—	73	1,668
2017	—	62	946
2016	—	75	1,231
2015	—	57	548

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,496Scopus Q3Diamond OASCImago Profile

Scopus Coverage:1960-1961, 1963-2025

•

Scopus Broad Areas:Immunology and MicrobiologyMedicine

Scopus Citation Rank (SJR)Q3

0.62

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

1.95

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations419

3-Year Documents215

Citable Documents170

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate53.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ3

Immunology and AllergyQ3

RheumatologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 7.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区RHEUMATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

The journal enforces rigorous peer evaluation with an annual output of approximately 73 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with Diamond Open Access (100% free of author APC charges). It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.